|
Exjade, the new hope for thalassemia |
|
Thursday, 19 January 2006 |
 Exjade® (Deferasirox), the breakthrough once-daily iron chelator from Novartis has received US FDA approval on last November. Exjade is an easy to administer novel oral iron chelator, Exjade is taken once daily, after dispersing tablets in a glass of water or orange juice (100-200 ml). Exjade well tolerated, safe and effective in reducing total body iron in patients with thalassemia.
Read more... |
|
FerriScan for iron overload |
|
Monday, 16 January 2006 |
 FerriScan is a magnetic resonance imaging (MRI)- based new technology for the non-invasive measurement of liver iron concentrations.
In the past, liver iron concentration was only able to be measured by liver needle biopsy, an invasive and often painful procedure. Now there is FerriScan which is more accurate, non-invasive,safer and quicker procedure. It gives patients and clinicians the information needed for diagnosis and planning treatment of iron overload in thalassemia. The test received FDA approval on January 2006. |
|
|
<< Start < Prev 1 2 Next > End >>
|
| Results 14 - 15 of 15 |
